Modern Authentication of Pharmaceuticals Act of 2025
U.S. Congress · HR1060 ·
What the bill says
Introduced 2025-02-06. Latest action: Referred to the House Committee on Energy and Commerce.
Summary (plain-language)
Modern Authentication of Pharmaceuticals Act of 2025 This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable. The bill applies to products manufactured beginning five years after the bill's enactment.
Sponsors
Text versions
- Introduced in House — 2025-02-06 — XML
What analysts say
No nonpartisan analysis on file for this measure yet.
What politicians say
No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.
Action History
| Date | Action |
|---|---|
| 2025-02-06 | Sponsor introductory remarks on measure. (CR H519) |
| 2025-02-06 | Introduced in House |
| 2025-02-06 | Referred to the House Committee on Energy and Commerce. |